Assessment of susceptibility to metronidazole and vancomycin of Clostridium difficile strains isolated between 1998-2002;Ocena wrażliwości na metronidazol i wankomycynȩ szczepów Clostridium difficile izolowanych z przewodu pokarmowego chorych z biegunka̧ poantybiotykowa̧ (AAD) hospitalizowanych w latach 1998-2002

Medycyna Doswiadczalna i Mikrobiologia

Volumn 55, Issue 3, 2003, Pages 253-258

  Pituch, Hanna ^a   Obuch Woszczatyński, Piotr ^a   Glinka, Dorota ^a   Łazińska, Bozena ^a   Meisel Mikołaczyk, Felicja ^a   Łuczak, Mirosław ^a  

^a AM   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CEFOXITIN; CYCLOSERINE; METRONIDAZOLE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CLOSTRIDIUM DIFFICILE; DIARRHEA; DRUG CHOICE; HOSPITALIZATION; HUMAN; LABORATORY TEST; NONHUMAN; STRAIN DIFFERENCE; STRAIN IDENTIFICATION; DRUG EFFECT; GENETICS; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; PSEUDOMEMBRANOUS COLITIS;

ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMANS; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; VANCOMYCIN;

EID: 0142011677     PISSN: 00258601     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Barbut F, Petit JC. Epidemiology of Clostridium difficile-associated infections. C Microbiol Infect 2001; 7: 405-10.
2. Bliss D, Johnson S, Savik K i inni. Acquisition of Clostridium diffcile Clostridum difficile-associated diarrhea in hospitalized patients receiving tube feeding. Ann Intern Med 1998; 129: 1012-9.
3. Bolton RP, Culshaw MA. Faecal metronidazole concentrations during oral and intravenous therapy from antibiotic associated colitis due to Clostridium difficile. Gut 1987; 27: 1169-72.
4. Boriello SP. Pathogenesis of Clostridium difficile infection. J Antimicrobiol Chemother 1998; 41: 13-9.
5. Brazier JS. The epidemiology and typing of Clostridium difficile. J Antimicrobiol Chemother 1998; 41: 47-57.
6. Dworczyński A, Sokół B, Meisel-Mikołajczyk F. Antibiotic resistance of Clostridium difficile isolates. Cytobios 1991; 65: 149-53
7. Fekety R. Guidelines for the diagnosis and management of Clostridium difficile associated diarrhea and colitis. Am J Gastroenterol 1997; 92: 739-50.
8. Gorbach SL. Antibiotics and Clostridium difficile. N Engl J Med 1999; 341: 1690- 92.
9. Jang SS, Hansen LM, Breher JE i inni. Antimicrobial susceptibilities of equine isolates of Clostridium difficile and molecular characterization of metronidazole-resistant. Clin Infect Dis 1997; 25: 266-7.
10. Kato H, Kato N, Katow S i inni. Deletions in the repeating sequences of the toxin A gene of toxin A-negative, toxin B positive Clostridium difficile strains. FEMS Microbiol Lett 175: 197-203
11. Kyne L, Kelly CP. Reccurent Clostridium difficile diarrhea. Gut 2001; 49:152-53.
12. Mc Coubrey J, Martin H, Starr JM i inni. Clostridium difficile in a geriatric unit: a prospective study. An international Congress of the Confederation of Anaerobe Societies. Abstract Book, Anaerobe". 2000.10-12 VII. 2000 abst. nrVIII-02 str. 166.
13. Mylonakis E, Ryan ET, Calderwood SB. Clostridium difficile-associatd diarrhoea: a review. Arch Intern Med 2001; 161: 525-33.
14. National Committee for Clinical Laboratory Standards. 2001. Methods for antimicrobial susceptibility testing of anaerobic bacteria; approved standard, 5th ed. NCCLS document M11-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
15. Pelaez T, Sanchez R, BlazquezR.i inni. Metronidazole resistance in Clostridium difficile: a new emerging problem? Program and abstracts of the 34th Internsci Conf Antimicrob Agents and Chemother 1994, E-34: 50
16. Pelaez T, Alcala L, Alonso R i inni. Reassesment of Clostridium difficile susceptibility to metronidazol and vancomycin. Antimicrob Agents Chemoth 2002; 46: 1647-50.
17. Pituch H, van den Braak N, van Leeuwen W i inni. Clonal dissemination of a toxin A -negative/toxin B- positive Clostridium difficile strains from patients with antibiotic-associated diarrhea in Poland. Clin Microbiol Infect 2001; 7: 442-6.
18. Pituch H. Flora bakteryjna izolowana z kału osób z podejrzeniem biegunki poantybiotykowej. Rozprawa doktorska. 2002. Akademia Medyczna w Warszawie.
19. Poxton IR, McCoubray J, Blair G. The pathogenicity of Clostridium difficile. Clin Microbiol Infect 2001; 7: 421-7.
20. Tabaqchali S, Jumaa P. Diagnosis and management of Clostriidum difficile infection. B. M. J. 1995; 310:1375-80.
21. Wong S S, Woo PC, Luk WK i inni. Susceptibility testing of Clostridium difficile against metronidazol and vancomycin by disc diffusion and E-test. Diagn Microbiol Infect. Dis 1999;34:1-6.